Interventional Cardiology Devices: A Global Strategic Business Report
San Jose, California (Vocus) June 15, 2010 –
Cardiovascular diseases represent one of the major causes of death worldwide, affecting more than 60 million individuals in the US alone. Interventional cardiologists are leveraging advancements in the medical field to perform various cardiovascular diagnosis and treatment procedures using minimally invasive techniques such as catheter-based interventional procedures. The treatment of coronary and peripheral artery diseases is now being performed using diagnostic procedures such as angiography, and interventional procedures such as stenting and angioplasty.
Interventional cardiology currently represents a successful minimally invasive technique for the diagnosis and therapeutic treatment of cardiac diseases such as coronary artery disease, peripheral arterial disease and heart valve disease. Angioplasty is perhaps the most widely performed interventional cardiology procedure, while other important procedures include valvuloplasty, congenial heart defect correction, percutaneous valve replacement, coronary thrombectomy and cardiac ablation. Interventional cardiology devices represent one of the fastest developing areas in the overall cardiovascular market.
While the developed United States, Europe and Japan represent mature interventional cardiology devices markets, the Asia-Pacific region constitutes a rapidly expanding market as stated by the new market research report on Interventional Cardiology Market. Cardiac Stents, with a share of about 45%, represents the largest segment of the world interventional cardiology devices market. Aging population constitutes the real growth engine for worldwide Coronary stent market. People above the age of 40-45 years run a high risk of developing heart/coronary diseases. The US followed by Europe represents the largest market for drug eluting stents. Asia-Pacific represents the fastest growing market, with China as both the largest and fastest growing market within Asia-Pacific, followed by India. Stent coatings that combine higher biocompatibility with controlled drug release characteristics over different medications that are in pipeline for vascular applications would have competitive edge in the drug-eluting stents market.
Intravascular Ultrasound represent fastest growing segments of the market. The vascular sealings market, which comprises of implantable devices and external compression products, has remained concentrated in the US and Western Europe.
Interventional cardiology is a consolidated marketplace with few players controlling a significant pie of the overall market. Key players profiled in the report include Boston Scientific, Cordis Corporation, Medtronic, and Abbott Laboratories.
The report titled “Interventional Cardiology Devices: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a review of noteworthy market trends, growth drivers and challenges. The report in addition also enumerates recent acquisitions, and other strategic industry activities. The report offers sales estimates and projections for world Interventional Cardiology Devices market by product segments, including cardiac stents, Peripheral Devices, Angioplasty Catheters, Intravascular Ultrasound, vascular sealings and Others. Regions analyzed include the US, Japan, Europe, Asia-Pacific (Excl. Japan) and Rest of World markets.
For more details about this market research report, please visit –
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world’s largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.